Relenza-Biota Holdings All of a sudden numerous people are coming down with a weird flu that starts with a mild cough then degenerates into a miserable flu situation and a lingering cough. It’s knocking people out left and right. For a few years there has been this remarkable flu medicine on the market, but it seems poorly marketed no thanks to the partners. The product was developed in Australia and I suspect that in the normal way business operates, the bigger pharmcos are just going to wait until the patent ends. If you begin using it within 48 hours of onset, it turns the flu into a mild cold without the sore throat. That’s my experience and heaven forbid that I am pretending to know anything at all since I am no doctor and do not pretend to be one and cannot actually recommend any such course of treatment (does that cover the legal stuff? I hope so. Read about it yourself). This much I know: You nearly have to beg a doctor to prescribe it since there are no salesmen pushing the product. Ask yourself why you’ve never heard of it. In my opinion since you only have 48 hours to begin treatment, you should always have some on hand. The drawback is that it’s very pricey. It depends on what your time is worth.
Biota’s Relenza — (Zanamivir) represents a new class of antiviral drugs and a new way to treat the influenza virus, more commonly known as “the flu”. Relenza works simply and directly by preventing the spread of influenza from one cell to another within the respiratory tract. To target the site of infection directly, Relenza is inhaled to the airways where the flu virus replicates. With this approach, the medication begins to function within seconds to immobilise and kill the influenza virus.
